• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Mindray’s sales, profits see double-digit gains | Earnings roundup

Mindray’s sales, profits see double-digit gains | Earnings roundup

March 1, 2011 By MassDevice staff

MassDevice.com Earnings Roundup

MassDevice keeps a close eye on public medical device companies, tracking their quarterly sales and earnings reports. For the most recent filings, check out our Earnings Roundup, where we collect each quarter’s reports.

Here’s a quick rundown of a few releases over the past couple days:

Mindray’s sales, profits see double-digit gains
Mindray Medical International Ltd. (NYSE:MR) reported profits of $41.0 million or 35 cents per diluted share, on sales of $211.0 million during the three months ended Dec. 31. That compares with profits of $37.4 million, or 33 cents per diluted share, on sales of $188.8 million during the same period last year.

Full-year profits were $155.5 million, or $1.32 per diluted share, on sales of $704.3 million. That compares with profits of $139.2 million, or $1.23 per diluted share, on sales of $634.2 million in 2009.
Read more

LeMaitre sees earnings quadruple; Q4 outstrips full 2009
LeMaitre Vascular Inc. (NSDQ:LMAT) reported profits of $2.1 million, or 13 cents per diluted share, on sales of $14.4 million during the three months ended Dec. 31. That compares with profits of $1.3 million, or 8 cents per diluted share, on sales of $13.6 million during the same period last year.

Full-year profits were $6.2 million, or 38 cents per diluted share, on sales of $56.1 million. That compares with profits of $1.6 million, or 10 cents per diluted share, on sales of $50.9 million in 2009.
Read more

NuVasive profits rocket
NuVasive Inc. (NYSE:NUVA) reported profits of $61.9 million, or $1.39 per diluted share, on sales of $129.3 million during the three months ended Dec. 31. That compares with a profits of $2.3 million, or 6 cents per diluted share, on sales of $106.9 million during the same period in 2009.

Full-year profits were $78.3 million, or $1.85 per diluted share, on sales of $478.2 million. That compares with profits of $5.8 million, or 15 cents per diluted share, on sales of $370.3 million in 2009.
Read more

Stereotaxis losses ease significantly despite modest revenue growth
Stereotaxis Inc. (NSDQ:STXS) reported losses of $2.5 million, or 5 cents per diluted share, on sales of $14.5 million during the three months ended Dec. 31, 2010. That compares with losses of $6.7 million, or 14 cents per diluted share, on sales of $14.1 million during the same period in 2009.

Full-year losses were $19.9 million, or 39 cents per diluted share, on sales of $54.1 million. That compares with losses of $27.5 million, or 63 cents per diluted share, on sales of $51.1 million in 2009.
Read more

Exactech sales jump 26 percent
Exactech Inc. (NSDQ:EXAC) reported profits of $2.7 million, or 21 cents per diluted share, on sales of $51.8 million during the three months ended Dec. 31, 2010. That compares with profits of about $494,000, or 4 cents per diluted share, on sales of $48.3 million during the same period in 2009.

Full-year profits were $10.5 million, or 80 cents per diluted share, on sales of $190.5 million. That compares with profits of $8.3 million, or 65 cents per diluted share, on sales of $177.3 million in 2009.
Read more

Filed Under: MassDevice Earnings Roundup, News Well Tagged With: Exactech Inc., LeMaitre Vascular Inc., Mindray Medical International Ltd., Nuvasive, Q4, Stereotaxis

More recent news

  • Neuralink files to raise $649M in new equity offering
  • BofA: Surgical robot remanufacturing not a major setback for Intuitive
  • InspireMD wins CE Mark approval for CGuard Prime
  • Philips reports first cases for VeriSight Pro 3D ICE catheter in Europe
  • Ceryx Medical raises $15M to support bioelectronic pacemaker

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy